Anti-DLGP1/ DLGAP1/ DAP-1 monoclonal antibody

Anti-DLGP1/ DLGAP1/ DAP-1 antibody for FACS & in-vivo assay

Target products collectionGo to DLGAP1/DLGAP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2396-Ab-1/ GM-Tg-hg-MP2396-Ab-2Anti-Human DLGAP1 monoclonal antibodyHuman
GM-Tg-rg-MP2396-Ab-1/ GM-Tg-rg-MP2396-Ab-2Anti-Rat DLGAP1 monoclonal antibodyRat
GM-Tg-mg-MP2396-Ab-1/ GM-Tg-mg-MP2396-Ab-2Anti-Mouse DLGAP1 monoclonal antibodyMouse
GM-Tg-cynog-MP2396-Ab-1/ GM-Tg-cynog-MP2396-Ab-2Anti-Cynomolgus/ Rhesus macaque DLGAP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2396-Ab-1/ GM-Tg-felg-MP2396-Ab-2Anti-Feline DLGAP1 monoclonal antibodyFeline
GM-Tg-cang-MP2396-Ab-1/ GM-Tg-cang-MP2396-Ab-2Anti-Canine DLGAP1 monoclonal antibodyCanine
GM-Tg-bovg-MP2396-Ab-1/ GM-Tg-bovg-MP2396-Ab-2Anti-Bovine DLGAP1 monoclonal antibodyBovine
GM-Tg-equg-MP2396-Ab-1/ GM-Tg-equg-MP2396-Ab-2Anti-Equine DLGAP1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2396-Ab-1/ GM-Tg-hg-MP2396-Ab-2; GM-Tg-rg-MP2396-Ab-1/ GM-Tg-rg-MP2396-Ab-2;
GM-Tg-mg-MP2396-Ab-1/ GM-Tg-mg-MP2396-Ab-2; GM-Tg-cynog-MP2396-Ab-1/ GM-Tg-cynog-MP2396-Ab-2;
GM-Tg-felg-MP2396-Ab-1/ GM-Tg-felg-MP2396-Ab-2; GM-Tg-cang-MP2396-Ab-1/ GM-Tg-cang-MP2396-Ab-2;
GM-Tg-bovg-MP2396-Ab-1/ GM-Tg-bovg-MP2396-Ab-2; GM-Tg-equg-MP2396-Ab-1/ GM-Tg-equg-MP2396-Ab-2
Products NameAnti-DLGAP1 monoclonal antibody
Formatmab
Target NameDLGAP1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DLGAP1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species DLGP1/ DLGAP1/ DAP-1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm004795mouse Dlgap1 Lentivirus plasmid
    ORF Viral VectorvGMLPm004795mouse Dlgap1 Lentivirus particle


    Target information

    Target IDGM-MP2396
    Target NameDLGAP1
    Gene ID9229,224997,65040,694049,480194,101084321,526435,100051510
    Gene Symbol and Synonyms4933422O14Rik,9630002F18,D17Bwg0511e,DAP-1,DAP-1-ALPHA,DAP-1-BETA,DAP1,DLGAP1,DLGAP1A,DLGAP1B,GKAP,GKAP/SAPAP,GKAP/SAPAP1,GKPA/SAPAP,mKIAA4162,rGKAP,SAPAP1
    Uniprot AccessionO14490,P97836
    Uniprot Entry NameDLGP1_HUMAN,DLGP1_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000170579
    Target ClassificationN/A

    The target: DLGAP1, gene name: DLGAP1, also named as DAP-1, DAP-1-ALPHA, DAP-1-BETA, DAP1A, DLGAP1B, GKAP, SAPAP1, DLGAP1. Predicted to enable molecular adaptor activity. Predicted to be a structural constituent of postsynaptic density. Predicted to be involved in several processes, including aggresome assembly; regulation of postsynaptic neurotransmitter receptor activity; and regulation of proteasomal protein catabolic process. Predicted to be located in plasma membrane. Predicted to be part of postsynaptic density. Predicted to be active in glutamatergic synapse and postsynaptic density, intracellular component. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.